tyrosyl-prolyl-leucyl-glycinamide has been researched along with clonazepam in 2 studies
Studies (tyrosyl-prolyl-leucyl-glycinamide) | Trials (tyrosyl-prolyl-leucyl-glycinamide) | Recent Studies (post-2010) (tyrosyl-prolyl-leucyl-glycinamide) | Studies (clonazepam) | Trials (clonazepam) | Recent Studies (post-2010) (clonazepam) |
---|---|---|---|---|---|
109 | 0 | 0 | 2,719 | 239 | 519 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ge, LJ; Kastin, AJ; Zadina, JE | 1 |
Greenblatt, DJ; Kastin, AJ; Miller, LG | 1 |
2 other study(ies) available for tyrosyl-prolyl-leucyl-glycinamide and clonazepam
Article | Year |
---|---|
Tyr-MIF-1 binding in brain is not altered by ligands selective for the GABAA/benzodiazepine receptor.
Topics: Animals; Brain; Clonazepam; Flunitrazepam; gamma-Aminobutyric Acid; Male; MSH Release-Inhibiting Hormone; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Neurotransmitter | 1990 |
Tyr-MIF-1 augments benzodiazepine receptor binding in vivo.
Topics: Animals; Brain Chemistry; Clonazepam; Male; Mice; MSH Release-Inhibiting Hormone; Receptors, GABA-A | 1987 |